Association of Bone Metabolism Markers with Coronary Atherosclerosis and Coronary Artery Disease in Postmenopausal Women

Overview

Journal J Bone Miner Metab

Specialty Endocrinology

Date 2017 Jun 24

PMID 28642975

Citations 4

Authors

Yan Ling

Zhen Wang

Bingjie Wu

Xin Gao

Affiliations

Soon will be listed here.

Abstract

This study aimed to evaluate the association of bone metabolism markers with coronary atherosclerosis and coronary artery disease (CAD) in postmenopausal women. Based on the findings of coronary angiography, 111 women with CAD and 116 women without CAD were recruited. Serum calcium, phosphate, parathyroid hormone (PTH), 25-hydroxyvitamin D (25OHD), osteocalcin, N-terminal propeptide of type I procollagen (P1NP) and C-terminal cross-linked telopeptide of type I collagen (CTX) were measured. The Gensini score was used to assess the severity of coronary atherosclerosis. Compared with women with serum calcium ≤2.29 mmol/L, women with serum calcium >2.29 mmol/L had a 2.63-fold increased risk of CAD after adjusting for multiple cardiovascular risks, PTH and 25OHD [odds ratio (OR) = 2.91, 95% confidence interval (CI) 1.35-6.28]. In the fully adjusted model plus PTH and 25OHD, the risk of CAD increased 1.87-fold with every 1-SD increment of serum calcium (OR = 1.87, 95% CI 1.21-2.88). To further analyze the potential strong confounding effect of albumin, the absolute levels of calcium were replaced by their albumin-corrected values in the regression model. Compared with women with albumin-corrected calcium ≤2.27 mmol/L, women with albumin-corrected calcium >2.27 mmol/L had a 2.36-fold increased risk of CAD in the fully adjusted model plus PTH and 25OHD (OR = 2.36, 95% CI 1.13-4.92). The risk of coronary atherosclerosis as defined by Gensini score >0 increased 1.73-fold with every 1-SD increment of serum calcium in the fully adjusted model plus PTH and 25OHD (OR = 1.73, 95% CI 1.09-2.73). However, albumin-corrected calcium was not associated with coronary atherosclerosis either as a categorical variable or as a continuous variable in all models. No significant association of PTH, 25OHD, osteocalcin, CTX and P1NP with CAD or coronary atherosclerosis was found in this study. Higher serum calcium levels were independently associated with CAD in postmenopausal women.

Citing Articles

Effects of Exercises of Different Intensities on Bone Microstructure and Cardiovascular Risk Factors in Ovariectomized Mice.

Wang X, Kang Y, Yao J, Gao X, Feng Z, Song Y Int J Mol Sci. 2025; 26(3).

PMID: 39940771 PMC: 11817207. DOI: 10.3390/ijms26031005.

Urinary Phosphate and Subclinical Atherosclerosis: The AWHS Study.

Torrijo-Belanche C, Moreno-Franco B, Laclaustra M, Gimeno-Ruiz S, Calvo-Galiano N, Rey-Garcia J Nutrients. 2024; 16(16).

PMID: 39203916 PMC: 11357142. DOI: 10.3390/nu16162780.

High Serum Phosphate Is Associated with Cardiovascular Mortality and Subclinical Coronary Atherosclerosis: Systematic Review and Meta-Analysis.

Torrijo-Belanche C, Moreno-Franco B, Munoz-Cabrejas A, Calvo-Galiano N, Casasnovas J, Sayon-Orea C Nutrients. 2024; 16(11).

PMID: 38892532 PMC: 11174514. DOI: 10.3390/nu16111599.

Undercarboxylated osteocalcin is associated with vascular function in female older adults but does not influence vascular function in male rabbit carotid artery ex vivo.

Tacey A, Smith C, Woessner M, Chubb P, Neil C, Duque G PLoS One. 2020; 15(11):e0242774.

PMID: 33237935 PMC: 7688178. DOI: 10.1371/journal.pone.0242774.

Bone mass density and bone metabolism marker are associated with progression of carotid and cardiac calcified plaque in Chinese elderly population.

Liu D, Chen L, Dong S, Peng Z, Yang H, Chen Y Osteoporos Int. 2019; 30(9):1807-1815.

PMID: 31190121 DOI: 10.1007/s00198-019-05031-5.

References

Hagstrom E, Michaelsson K, Melhus H, Hansen T, Ahlstrom H, Johansson L . Plasma-parathyroid hormone is associated with subclinical and clinical atherosclerotic disease in 2 community-based cohorts. Arterioscler Thromb Vasc Biol. 2014; 34(7):1567-73. DOI: 10.1161/ATVBAHA.113.303062. View

Grandi N, Brenner H, Hahmann H, Wusten B, Marz W, Rothenbacher D . Calcium, phosphate and the risk of cardiovascular events and all-cause mortality in a population with stable coronary heart disease. Heart. 2012; 98(12):926-33. DOI: 10.1136/heartjnl-2011-300806. View

Gallo L, Faniello M, Canino G, Tripolino C, Gnasso A, Cuda G . Serum Calcium Increase Correlates With Worsening of Lipid Profile: An Observational Study on a Large Cohort From South Italy. Medicine (Baltimore). 2016; 95(8):e2774. PMC: 4779001. DOI: 10.1097/MD.0000000000002774. View

Gossl M, Modder U, Atkinson E, Lerman A, Khosla S . Osteocalcin expression by circulating endothelial progenitor cells in patients with coronary atherosclerosis. J Am Coll Cardiol. 2008; 52(16):1314-25. PMC: 2613163. DOI: 10.1016/j.jacc.2008.07.019. View

Stevens L, Coresh J, Greene T, Levey A . Assessing kidney function--measured and estimated glomerular filtration rate. N Engl J Med. 2006; 354(23):2473-83. DOI: 10.1056/NEJMra054415. View

Kim K, Lim S, Moon J, Jin H, Jung K, Shin C . Lower uncarboxylated osteocalcin and higher sclerostin levels are significantly associated with coronary artery disease. Bone. 2015; 83:178-183. DOI: 10.1016/j.bone.2015.11.008. View

Bansal N, Zelnick L, Robinson-Cohen C, Hoofnagle A, Ix J, Lima J . Serum parathyroid hormone and 25-hydroxyvitamin D concentrations and risk of incident heart failure: the Multi-Ethnic Study of Atherosclerosis. J Am Heart Assoc. 2014; 3(6):e001278. PMC: 4338718. DOI: 10.1161/JAHA.114.001278. View

Tyson K, Reynolds J, McNair R, Zhang Q, Weissberg P, Shanahan C . Osteo/chondrocytic transcription factors and their target genes exhibit distinct patterns of expression in human arterial calcification. Arterioscler Thromb Vasc Biol. 2003; 23(3):489-94. DOI: 10.1161/01.ATV.0000059406.92165.31. View

Giachelli C . Vascular calcification mechanisms. J Am Soc Nephrol. 2004; 15(12):2959-64. DOI: 10.1097/01.ASN.0000145894.57533.C4. View

10.

Williams D, Fraser A, Lawlor D . Associations of vitamin D, parathyroid hormone and calcium with cardiovascular risk factors in US adolescents. Heart. 2011; 97(4):315-20. PMC: 3931194. DOI: 10.1136/hrt.2010.203224. View

11.

Bosworth C, Sachs M, Duprez D, Hoofnagle A, Ix J, Jacobs Jr D . Parathyroid hormone and arterial dysfunction in the multi-ethnic study of atherosclerosis. Clin Endocrinol (Oxf). 2013; 79(3):429-36. PMC: 3664253. DOI: 10.1111/cen.12163. View

12.

Mizobuchi M, Towler D, Slatopolsky E . Vascular calcification: the killer of patients with chronic kidney disease. J Am Soc Nephrol. 2009; 20(7):1453-64. DOI: 10.1681/ASN.2008070692. View

13.

Zhang Y, Qi L, Gu W, Yan Q, Dai M, Shi J . Relation of serum osteocalcin level to risk of coronary heart disease in Chinese adults. Am J Cardiol. 2010; 106(10):1461-5. DOI: 10.1016/j.amjcard.2010.07.013. View

14.

Leli C, Pasqualini L, Vaudo G, Gaggioli S, Scarponi A, Mannarino E . Carotid intima-media thickness and bone turnover: the role of C-terminal telopeptide of type I collagen. Intern Emerg Med. 2010; 5(2):127-34. DOI: 10.1007/s11739-010-0356-y. View

15.

Yang R, Ma X, Dou J, Wang F, Luo Y, Li D . Relationship between serum osteocalcin levels and carotid intima-media thickness in Chinese postmenopausal women. Menopause. 2013; 20(11):1194-9. DOI: 10.1097/GME.0b013e31828aa32d. View

16.

Shin S, Kim K, Chang H, Cho I, Kim Y, Choi B . Impact of serum calcium and phosphate on coronary atherosclerosis detected by cardiac computed tomography. Eur Heart J. 2012; 33(22):2873-81. DOI: 10.1093/eurheartj/ehs152. View

17.

Yao L, Folsom A, Pankow J, Selvin E, Michos E, Alonso A . Parathyroid hormone and the risk of incident hypertension: the Atherosclerosis Risk in Communities study. J Hypertens. 2016; 34(2):196-203. PMC: 4755355. DOI: 10.1097/HJH.0000000000000794. View

18.

Kwak S, Kim J, Choi Y, Chang Y, Kwon M, Jung J . Dietary intake of calcium and phosphorus and serum concentration in relation to the risk of coronary artery calcification in asymptomatic adults. Arterioscler Thromb Vasc Biol. 2014; 34(8):1763-9. DOI: 10.1161/ATVBAHA.114.303440. View

19.

Bergwitz C, Juppner H . Regulation of phosphate homeostasis by PTH, vitamin D, and FGF23. Annu Rev Med. 2010; 61:91-104. PMC: 4777331. DOI: 10.1146/annurev.med.051308.111339. View

20.

STARY H, Chandler A, Dinsmore R, Fuster V, Glagov S, INSULL Jr W . A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation. 1995; 92(5):1355-74. DOI: 10.1161/01.cir.92.5.1355. View